Heartland Bank & Trust CO Edwards Lifesciences Corp Transaction History

Heartland Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 21, 2024	BUY	$84.3 - $94.31 $535,052 - $598,585	6,347 New	6,347 $586,000
Q2 2022 Jul 12, 2022	BUY	$86.5 - $128.27 $186,148 - $276,037	2,152 Added 25.5%	10,590 $1.01 Million
Q1 2022 Apr 12, 2022	BUY	$101.96 - $128.34 $244,296 - $307,502	2,396 Added 39.66%	8,438 $993,000
Q4 2021 Feb 04, 2022	BUY	$106.37 - $130.68 $642,687 - $789,568	6,042 New	6,042 $783,000
Q2 2021 Jul 30, 2021	SELL	$83.84 - $104.76 $523,245 - $653,807	-6,241 Closed	0 $0
Q1 2021 Jun 21, 2021	BUY	$78.68 - $90.67 $108,657 - $125,215	1,381 Added 28.42%	6,241 $522,000
Q4 2020 Jun 15, 2021	BUY	$71.69 - $91.23 $348,413 - $443,377	4,860 New	4,860 $443,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Heartland Bank & Trust CO with notifications on news.